US Edition
New drug ‘could boost effectiveness of chemotherapy’, developers say
- The drug KCL-HO-1i, developed by experts at King's College London, could enhance chemotherapy effectiveness by disarming tumor protection mechanisms.
- Early tests showed that KCL-HO-1i helped chemotherapy-resistant tumors respond to treatment in mice, leading researchers to hope for future human trials.
- Professor James Spicer stated that current chemotherapy often fails to be effective and long-lasting, highlighting the importance of this research.
- If successful in trials, KCL-HO-1i could reduce the need for aggressive cancer treatments, improving patient outcomes.
Insights by Ground AI
Does this summary seem wrong?
47 Articles
47 Articles
New drug may boost chemotherapy in resistant cancers
A tablet developed at King’s College London could make chemotherapy more effective by blocking a tumour’s key defence protein, early studies show A team of King’s College London scientists has developed a potential companion drug that could make chemotherapy effective even against treatment-resistant cancers. By targeting a tumour-shielding protein produced by immune cells, the tablet called KCL-HO-1i has shown promising results in preclinical m…
Coverage Details
Total News Sources47
Leaning Left3Leaning Right0Center34Last UpdatedBias Distribution92% Center
Bias Distribution
- 92% of the sources are Center
92% Center
C 92%
Factuality
To view factuality data please Upgrade to Premium
